Strides Pharma Science Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
1,229.52
1,100.22
1,070.49
1,046.42
1,035.28
Other Income Qtr Cr28.4112.72-13.558.7535.85
Operating Revenues Qtr1,201.111,087.501,084.041,037.67999.43

*All values are in Cr.

Operating Expenses Qtr
965.30
870.52
854.30
843.86
846.30
Operating Profit Qtr
235.81
216.98
229.73
193.81
153.13
EBIDT Qtr Cr
260.35
225.96
208.19
246.65
24.05
Depreciation Qtr
50.52
48.59
49.76
51.23
60.10
Net Profit Qtr
93.23
70.20
18.18
49.67
-131.34
Basic EPS Qtr
10.14
7.64
1.98
5.43
-14.54
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -